Skip to content

Dry Needling Treatment in Hemiplegic Shoulder Pain

Does Dry Needling Treatment Make an Extra Contribution to Conventional Treatment in Hemiplegic Shoulder Pain?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790071
Enrollment
46
Registered
2021-03-10
Start date
2022-10-01
Completion date
2023-04-09
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia, Myofascial Pain, Shoulder Pain

Keywords

Hemiplegic shoulder pain, Conventional treatment, Dry needling

Brief summary

To evaluate the efficacy of dry needling therapy on shoulder pain and upper extremity functions in hemiplegic patients.

Detailed description

The myofascial trigger point is an overlooked issue in hemiplegic shoulder pain. Our aim in this study is to evaluate whether dry needling treatment contributes to the conventional treatment approach.

Interventions

OTHERConventional physical therapy

Conventional physical therapy: The patients received physical therapy to the shoulder, transcutaneous electrical nerve stimulation, and stretching and strengthening exercises (5 days per week for three weeks in a total of 15 sessions).

OTHERConventional physical therapy plus dry needling

Conventional physical therapy plus dry needling: The patients received physical therapy to the shoulder, including transcutaneous electrical nerve stimulation, stretching, and strengthening exercise (5 days per week for three weeks in a total of 15 sessions). And also, a total of 3 dry needling sessions were applied at 7-day intervals.

Sponsors

Kars State Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Prospective randomised controlled

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* The patients included in the study were aged between 30-60 years, with at least a 3-month history of hemorrhagic or ischemic stroke.

Exclusion criteria

* if they had severe difficulty in communication * had received a corticosteroid injection within 3 months prior to enrollment * had bleeding diathesis, a history of shoulder surgery * a preexisting painful shoulder disorder, or had a cardiac pacemaker.

Design outcomes

Primary

MeasureTime frameDescription
Change in visual analog scale score3 monthsIt grades pain of the patients between 0 and 10 points. Higher scores represent a worse outcome
Change in range of motion3 monthsShoulder range of motion of the patients is evaluated in abduction, flexion, and external rotation. Higher measurements represent a better outcome
Change in Quick The Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire score3 monthsThe Quick DASH is an 11-item measure of the magnitude of disability and symptoms specific to the upper extremity. The first 6 items measure the degree of difficulty in performing various physical activities because of a shoulder, arm, and hand problem, and the other 5 items related to quality of sleeping, social activities, and daily activities, and the intensity of pain and numbness.
Change in Fugl-Meyer Assessment score3 monthsThe FM scale is a 226-point multi-item Likert-type scale developed as an evaluative measure of recovery from hemiplegic stroke. It is divided into 5 domains: motor function, sensory function, balance, joint range of motion, and joint pain. Each domain contains multiple items, each scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026